An early trial for an experimental HIV vaccine candidate has shown promising results. 97% of recipients in a phase 1 study showed immune system activity in response to the vaccine. But there's a long ...

An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The ...

HIV is a wily and lethal replicator. In less than 25 years, it's killed more than 25 million people. Scientists are exploring exactly how this virus reproduces because they would like to find a way to ...

A mapmaker and a mathematician may seem like an unlikely duo, but together they worked out a way to measure longitude -- and kept millions of sailors from getting lost at sea. Now, another unlikely ...

A team of researchers studying HIV have created a test that they say will allow clinicians and scientists to better track efforts to cure the disease. Most HIV drugs attack the active virus, which ...

Using a simulation of more than 64 million atoms and a supercomputer named Blue Waters, researchers at the University of Illinois have created a digital model that could provide the key to curing HIV.

The HIV-1 Gag polyprotein precursor is necessary and sufficient for the formation of virus-like particles in Gag-expressing cells. Gag contains domains that are required for virus assembly and release ...

P-selectin glycoprotein ligand-1 (PSGL-1) is a dimeric, mucin-like, 120-kDa glycoprotein that binds to P-, E-, and L-selectins. PSGL-1 is expressed primarily on the surface of lymphoid and myeloid ...